NCT02271139 · Expanded access
Expanded Access Study of Alectinib for Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC) After Disease Progression on or Intolerance to Prior ALK Tyrosine Kinase Inhibitor Therapy
Overall registry status No longer available
Conditions Non-Small Cell Lung Cancer
Delaware Valley sites
- Cancer Treatment Centers of America - Eastern Regional Medical Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory